Jamaica, NY, United States of America

John D Loike

This inventor holds 6 USPTO granted patents and 2 published patent applications. Top assignees: Columbia University, Other. Active years: 1998-2021.

USPTO Granted Patents = 6 

% Patents Active = 66.7

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • Jamaica Estates, NY (US) (1998)
  • Jamaica, NY (US) (1999 - 2021)

Company Filing History:


Years Active: 1998-2021

Loading Chart...
6 patents (USPTO):Explore Patents

Title: John D Loike: Innovator in Immunotherapy

Introduction

John D Loike is a prominent inventor based in Jamaica, NY (US), known for his significant contributions to the field of immunotherapy. With a total of 6 patents, he has made remarkable strides in developing methods for treating infectious and neoplastic diseases.

Latest Patents

Loike's latest patents focus on innovative methods for treating subjects suffering from infectious or neoplastic diseases through immunotherapy. One of the methods involves determining the critical concentration of immune cells required to effectively treat or eradicate these diseases using an in vitro assay. This groundbreaking approach allows for the precise administration of immune cells to the subject, enhancing the efficacy of the treatment.

Career Highlights

Throughout his career, John D Loike has worked at Columbia University, where he has been involved in cutting-edge research and development in the medical field. His work has not only advanced scientific understanding but has also paved the way for new therapeutic strategies.

Collaborations

Loike has collaborated with notable colleagues, including Samuel C Silverstein and Sadna Budhu, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

John D Loike's contributions to immunotherapy exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements in the treatment of infectious and neoplastic diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…